MR Spectroscopy of Brain Tumors

Hall C
Tuesday: 13:30 – 15:30

1106.   Effect of MRS on Clinical Decision Making in Brain Tumor Management, A. Lin, A. Mamelak and B.D. Ross, Huntington Medical Research Institute and Huntington Memorial Hospital, Pasadena, CA, USA.
1107.   The Effect of Gd-DTPA on T1 Weighted Choline Signal In Human Brain Tumours, P.S. Murphy, A. Dzik-Jurasz, M.O. Leach and I. Rowland, The Institute of Cancer Research and The Royal Marsden NHS Trust, Sutton, Surrey, UK.
1108.   ¹H MRSI, rCBV, and ADC in Human Brain Tumors: A Correlation with Image-Guided Biopsies, M. Hanna, S. Noworolski, R. Henry, A. Bollen, M. Day, T. McKnight, M. McDermott, M. Berger, W. Dillon, S. Nelson and D. Vigneron, University of California, San Francisco, CA, USA.
1109.   Multi-Slice Proton Spectroscopic Imaging of Cerebral Gliomas in Untreated Patients, D.O. Hearshen, T. Mikkelsen, D. Peck, S. Patel and L.N. Scarpace, Henry Ford Health System, Detroit, MI, USA.
1110.   Regional Discrepancy of Apparent Diffusion Coefficient in Cerebral Gliomas: Correlation with Tumor rCBV and CSI, W-C. Wu, M-L. Wu, C-W. Ko, C-Y. Chen and H-W. Chung, National Taiwan University and Tri-Service General Hospital, Taipei, Taiwan, ROC.
1111.   Prospective Evaluation of Intracranial Cystic Mass Lesions with in vivo Proton MR Spectroscopy, A. Shukla-Dave, R.K. Gupta, R. Roy, D.K. Chhabra, N. Husain, L. Paul and M. Husain, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, KG Medical College and CDRI, Lucknow, India.
1112.   Assessment and Comparison of ¹H-MRSI Metabolite Ratios within the T2-Hyperintensity of Patients with Recurrent Gliomas of Different Grades and Cell Types, T.R. McKnight, S.G. Patel, W.P. Dillon and S.J. Nelson, University of California, San Francisco, CA, USA.
1113.   Preoperative Differentiation of Benign from Malignant Cerebral Glioma Using Perfusion EPI and CSI: Preliminary Results, C-W. Ko, W-C. Wu, M-L. Wu, C-Y. Chen and H-W. Chung, National Taiwan University and Tri-Service General Hospital, Taipei, Taiwan, ROC.
1114.   Three-Dimensional Diffusion, Perfusion and H1-Spectroscopy Measures in Gliomas, I. Catalaa, R. Henry, M. Hanna, T. Graves, S. Nelson and D. Vigneron, University of California, San Francisco, CA, USA.
1115.   Tumor Choline-to-Creatine MRS Signal Ratio is a Statistical Survival Predictor in Glioblastoma Multiforme Following Radiation Therapy, J.R. Alger, J.H. Harreld, D. Giunzioni and T.F. Cloughesy, University of California, Los Angeles, CA, USA.
1116.   Assessment of Tumor Response to Chemotherapy by Longitudinal Multislice ¹H MRSI, MRI and Clinical Examinations, M.A. Bania, C. Balmaceda, X. Mao, R.L. DeLaPaz and D.C. Shungu, Columbia University, New York, NY, USA.
1117.   An Early Increase in Choline in Proton Spectroscopic Imaging May Precede a Favorable Chemotherapy Effect in Glioma Patients, L. Kankaanranta, K. Vuori, A-M. Häkkinen, H. Mäenpää, A. Brander, H. Joensuu and N. Lundbom, Helsinki University Central Hospital, Helsinki, Finland.
1118.   Serial Evaluation of Gliomas Using a Multimodal Magnetic Resonance Approach: A Case Study of Patients in the Marimastat Phase II Clinical Trial, J.I. Lee, E.E Graves, S.J. Nelson, D.B. Vigneron and W.P. Dillon, University of California, San Francisco, CA, USA.
1119.   In vivo Temperature Measurements in Brain Tumors Using Localised Proton Spectroscopy, R. Jayasundar, All India Institute of Medical Sciences, New Delhi, India.

Return to ISMRM program